Clinical Trial Update: Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By Surgery [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of doxorubicin hydrochloride and alvocidib in patients with metastatic or recurrent soft tissue sarcoma and gastrointes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor
• Soft Tissue Sarcoma

Drugs mentioned

• Alvocidib (Flavopiridol)
• DOXORUBICIN HYDROCHLORIDE (Doxorubicin hydrochloride)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Gastrointestinal Stromal Tumor, Recurrent Adult Soft Tissue Sarcoma | Phase 1 | Status: COMPLETED